UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):  May 29, 2019

 

BIO-PATH HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-36333   87-0652870

(State or other jurisdiction

of incorporation)

  (Commission File Number)   (IRS Employer Identification No.)

 

4710 Bellaire Boulevard, Suite 210, Bellaire, Texas   77401
(Address of principal executive offices)   (Zip Code)

 

(832) 742-1357

(Registrant’s Telephone Number, Including Area Code)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which
registered
Common Stock, par value $0.001 per share   BPTH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01 Entry Into a Material Definitive Agreement.

 

As previously reported, on April 16, 2014, Bio-Path Holdings, Inc. (the “Company”) entered into a lease agreement (the “Lease Agreement”) with Pin Oak North Parcel TT, LLC for approximately 3,002 square feet of office space located at 4710 Bellaire Boulevard, Bellaire, Harris County, Texas 77401, having a term of sixty (60) months (the “Term”) beginning on August 1, 2014. On May 29, 2019, the Company entered into a first amendment (the “First Amendment”) to the Lease Agreement with Norvin Pin Oak North LLC, Norvin Pin Oak North II LLC, Norvin Pin Oak North III LLC, Norvin Pin Oak North IV LLC, Norvin Pin Oak North V LLC and Norvin Pin Oak North VI LLC, collectively the successor in interest to Pin Oak North Parcel TT, LLC to the Lease Agreement. The First Amendment provides for, among other things, an extension of the Term for an additional sixty-three (63) months beginning on August 1, 2019.

 

The foregoing description of the terms of the First Amendment does not purport to be complete and is qualified in its entirety by the full text of the First Amendment, which is filed herewith as Exhibit 10.1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits .

 

Exhibit  
Number
  Description
     
10.1   First Amendment to Lease Agreement dated May 29, 2019

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIO-PATH HOLDINGS, Inc.
   
Dated:  June 4, 2019 By: /s/ Peter H. Nielsen
    Peter H. Nielsen
    President and Chief Executive Officer

 

 

 

 

EXHIBIT INDEX

 

Exhibit
Number
  Description
     
10.1   First Amendment to Lease Agreement dated May 29, 2019

 

 

Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bio Path Charts.
Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bio Path Charts.